Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The multifaceted view of heart problem in Duchenne muscular dystrophy
Urszula Florczyk, Katarzyna Polak, Józef Dulak
Cellular and Molecular Life Sciences (2021)
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Cardiac dysregulation in Duchenne muscular dystrophy: An ECG analysis
Krishnamurthy Arjun, Ganagarajan Inbaraj, Adoor Meghana, et al.
Journal of Electrocardiology (2025) Vol. 91, pp. 154015-154015
Closed Access | Times Cited: 1
Amelioration of Morphological Pathology in Cardiac, Respiratory, and Skeletal Muscles Following Intraosseous Administration of Human Dystrophin Expressing Chimeric (DEC) Cells in Duchenne Muscular Dystrophy Model
Maria Siemionow, Katarzyna Budzynska, Kristina Zalants, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 586-586
Open Access | Times Cited: 4
Understanding the molecular basis of cardiomyopathy
Marie‐Louise Bang, Julius Bogomolovas, Ju Chen
AJP Heart and Circulatory Physiology (2021) Vol. 322, Iss. 2, pp. H181-H233
Open Access | Times Cited: 25
Histopathology of Duchenne muscular dystrophy in correlation with changes in proteomic biomarkers.
Margit Zweyer, Hemmen Sabir, Paul Dowling, et al.
PubMed (2022) Vol. 37, Iss. 2, pp. 101-116
Closed Access | Times Cited: 19
Evaluation of Creatine Monohydrate Supplementation on the Gastrocnemius Muscle of Mice with Muscular Dystrophy: A Preliminary Study
Victor Augusto Ramos Fernandes, Gabriela Pereira dos Santos, Amilton Iatecola, et al.
Pathophysiology (2025) Vol. 32, Iss. 1, pp. 2-2
Open Access
The latest developments in synthetic approaches to duchenne muscular dystrophy
Lucy M. Johnson, Tariq G. Pulskamp, Daniel J. Berlau
Expert Review of Neurotherapeutics (2025)
Closed Access
Cardiomyopathies and Arrythmias in Neuromuscular Diseases
Giuseppe Sgarito, Carmen Volpe, Stefano Bardari, et al.
Cardiogenetics (2025) Vol. 15, Iss. 1, pp. 7-7
Open Access
Cardioprotective Effects of Hydrogen Sulfide and Its Potential Therapeutic Implications in the Amelioration of Duchenne Muscular Dystrophy Cardiomyopathy
Agnieszka Łoboda, Józef Dulak
Cells (2024) Vol. 13, Iss. 2, pp. 158-158
Open Access | Times Cited: 3
Cardiomyopathy in Duchenne Muscular Dystrophy and the Potential for Mitochondrial Therapeutics to Improve Treatment Response
Shivam Gandhi, H. Lee Sweeney, Cora C. Hart, et al.
Cells (2024) Vol. 13, Iss. 14, pp. 1168-1168
Open Access | Times Cited: 3
Hydrogen sulfide as a therapeutic option for the treatment of Duchenne muscular dystrophy and other muscle-related diseases
Katarzyna Kaziród, Małgorzata Myszka, Józef Dulak, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 12
Open Access | Times Cited: 11
IPSC derived cardiac fibroblasts of DMD patients show compromised actin microfilaments, metabolic shift and pro-fibrotic phenotype
Salwa Soussi, Lesia Savchenko, Davide Rovina, et al.
Biology Direct (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 6
How Can Proteomics Help to Elucidate the Pathophysiological Crosstalk in Muscular Dystrophy and Associated Multi-System Dysfunction?
Paul Dowling, Capucine Trollet, Elisa Négroni, et al.
Proteomes (2024) Vol. 12, Iss. 1, pp. 4-4
Open Access | Times Cited: 2
Qualitative and Quantitative Electrocardiogram Parameters in a Large Cohort of Children with Duchenne Muscle Dystrophy in Comparison with Age-Matched Healthy Subjects: A Study from South India
Manu Santhappan Girija, Deepak Menon, Kiran Polavarapu, et al.
Annals of Indian Academy of Neurology (2024) Vol. 27, Iss. 1, pp. 53-57
Open Access | Times Cited: 2
Evaluation of the GSP Creatine Kinase-MM Assay and Assessment of CK-MM Stability in Newborn, Patient, and Contrived Dried Blood Spots for Newborn Screening for Duchenne Muscular Dystrophy
Brooke Migliore, Linran Zhou, Martin Duparc, et al.
International Journal of Neonatal Screening (2022) Vol. 8, Iss. 1, pp. 12-12
Open Access | Times Cited: 10
Proteome Profiling of the Dystrophic mdx Mice Diaphragm
Olga Mucha, Małgorzata Myszka, Paulina Podkalicka, et al.
Biomolecules (2023) Vol. 13, Iss. 11, pp. 1648-1648
Open Access | Times Cited: 5
Sarcoplasmic Reticulum Ca2+ Dysregulation in the Pathophysiology of Inherited Arrhythmia: An Update
Yuxin Du, Laurie J. Demillard, Jun Ren
Biochemical Pharmacology (2022) Vol. 200, pp. 115059-115059
Closed Access | Times Cited: 9
Characterization of the Cardiac Structure and Function of Conscious D2.B10-Dmdmdx/J (D2-mdx) mice from 16–17 to 24–25 Weeks of Age
Daria De Giorgio, Deborah Novelli, F. Motta, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11805-11805
Open Access | Times Cited: 5
Sunitinib inhibits STAT3 phosphorylation in cardiac muscle and prevents cardiomyopathy in the mdx mouse model of Duchenne muscular dystrophy
Ariany Oliveira‐Santos, Marisela Dagda, Dean J. Burkin
Human Molecular Genetics (2022) Vol. 31, Iss. 14, pp. 2358-2369
Open Access | Times Cited: 7
Mitochondria in Duchenne Muscular Dystrophy-induced Cardiomyopathy: A Prospective Therapeutic Target to Improve Treatment Response
Shivam Gandhi, H. Lee Sweeney, Cora C. Hart, et al.
(2024)
Open Access | Times Cited: 1
Targeted expression of heme oxygenase-1 in satellite cells improves skeletal muscle pathology in dystrophic mice
Urszula Florczyk, Katarzyna Polak, Šárka Jelínková, et al.
Skeletal Muscle (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Systemic Treatment of Body‐Wide Duchenne Muscular Dystrophy Symptoms
Patryk Konieczny
Clinical Pharmacology & Therapeutics (2024) Vol. 116, Iss. 6, pp. 1472-1484
Open Access | Times Cited: 1
Retrospective analysis of persistent HyperCKemia with or without muscle weakness in a case series from Greece highlights vast DMD variant heterogeneity
Kyriaki Kekou, Maria Svingou, Nikos Vogiatzakis, et al.
Expert Review of Molecular Diagnostics (2023) Vol. 23, Iss. 11, pp. 999-1010
Closed Access | Times Cited: 3
Perspectives on the advances in the pharmacotherapeutic management of Duchenne muscular dystrophy
Kelsie D. Kracht, Nicole L. Eichorn, Daniel J. Berlau
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 15, pp. 1701-1710
Closed Access | Times Cited: 4
[Clinical and genetic characteristics of children with primary dilated cardiomyopathy].
Kui Zheng, Fei Wu, Mei-Na Lou, et al.
PubMed (2023) Vol. 25, Iss. 7, pp. 726-731
Closed Access | Times Cited: 2
Cardiomyopathies in Children: Genetics, Pathomechanisms and Therapeutic Strategies
Diana Cimiotti, Seyyed‐Reza Sadat‐Ebrahimi, Andreas Mügge, et al.
IntechOpen eBooks (2023)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top